Skip to content
DraconiticResearch
Search Sources API
197,788 studies31 sourcesUpdated 1 h ago
Peer-reviewedCC BY 4.0Cureus

Giant Papillary Renal Cell Carcinoma: A Rare Case of a 31-cm Renal Mass With Suspected Metastatic Disease on Imaging

  1. 1Department of Radiology, King Khalid University Hospital, Riyadh, SAU
  2. 2College of Medicine, King Saud University, Riyadh, SAU

Abstract

Papillary renal cell carcinoma (pRCC) is a recognized subtype of renal cell carcinoma (RCC) with variable clinical and radiologic presentations. Exceptionally large tumors with metastatic involvement represent an unusual presentation. We report a case of a massive pRCC with metastatic disease, highlighting its aggressive clinical and radiologic features. A 50-year-old male presented with a right flank mass and abdominal pain persisting for several months. He had no history of smoking or known genetic syndromes. Laboratory investigations showed mild anemia and microscopic hematuria, while renal and liver function tests were within normal limits. Imaging studies, including computed tomography and magnetic resonance imaging, revealed a large centrally necrotic right renal mass measuring 24×19×31 cm, with associated lung and bone findings, concerning for metastases. A renal biopsy confirmed the diagnosis of papillary renal cell carcinoma.

This case highlights an atypical presentation of pRCC, with an exceptionally large tumor size, T2 hyperintensity, central necrosis, and radiologically suspected metastatic disease at the time of diagnosis. While pRCC is generally smaller, weakly enhancing, T2 hypointense, and less aggressive than clear cell RCC, this case demonstrates that exceptionally large renal masses may have atypical imaging appearances. Therefore, pRCC should remain within the differential diagnosis, and histopathological confirmation is required for definitive diagnosis. Management of metastatic pRCC should be individualized based on disease burden, resectability, patient factors, and available systemic treatment options. Further research is warranted to better understand the biological mechanisms underlying aggressive tumor behavior. This report aimed to highlight a rare case, emphasizing its clinical significance due to its unusual presentation, notable mass effect, complexities in differential diagnosis, and radiologically suspected metastatic involvement. Specifically, we describe a case involving a sizable, necrotic, and contrast-enhanced pRCC that deviates from the conventional clinical and radiological features commonly associated with this tumor subtype.

Related

  1. Two-year dynamic risk stratification and adjuvant radioiodine efficacy in initial non-distant metastatic papillary thyroid carcinoma harboring TERT promoter mutations
    Xian-Zhao Deng, Meng-yue Liu, Chen-Tian Shen +7
    Frontiers in oncologyPeer-reviewedCC BYFull textEndocrinology & metabolismEurope PMCCrossref
  2. Imaging features of synchronous bilateral primary tumors of oncocytic thyroid carcinoma and papillary thyroid carcinoma: A case report
    Qi-Shu Gong, Xiao-Wen Liu, Xun-Peng Luo +1
    World journal of radiologyPeer-reviewedCC BY-NCFull textEndocrinology & metabolismEurope PMCPMC
  3. Differentiation of C-TIRADS ultrasonic imaging features between mummified thyroid nodules and papillary thyroid carcinoma
    GU Yaoyao, NI Xuejun, YANG Qingrong +1
    Zhongguo linchuang yanjiuPeer-reviewedCC BY-NC-NDFull textEndocrinology & metabolismDOAJ
  4. Imaging patterns and diagnostic challenges in metastatic invasive lobular carcinoma
    Caroline Malhaire, F. Lecouvet, M. Bereby-Kahane +12
    European Journal of RadiologyPeer-reviewedCC BY1 citedMedical imaging & radiologyHAL
  5. Hybrid grading systems improve progression risk stratification in non‐invasive papillary urothelial carcinoma and support a histomorphological continuum of disease progression
    Jane K Nguyen, Marcello P Toscano, Jianbo Li +14
    HistopathologyPeer-reviewedCC BY 4.0Full text1 citedSurgery & anaesthesiaPMC
BibTeX
@article{aljuaid2026giant,
  title = {{Giant Papillary Renal Cell Carcinoma: A Rare Case of a 31-cm Renal Mass With Suspected Metastatic Disease on Imaging}},
  author = {Maram Aljuaid and Razan Alotaibi and Waad Abu Nakha},
  journal = {Cureus},
  year = {2026},
  month = oct,
  doi = {10.7759/cureus.117449},
  url = {https://doi.org/10.7759/cureus.117449},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Giant Papillary Renal Cell Carcinoma: A Rare Case of a 31-cm Renal Mass With Suspected Metastatic Disease on Imaging
AU  - Maram Aljuaid
AU  - Razan Alotaibi
AU  - Waad Abu Nakha
PY  - 2026
DA  - 2026/10/04
JO  - Cureus
DO  - 10.7759/cureus.117449
UR  - https://doi.org/10.7759/cureus.117449
AB  - Papillary renal cell carcinoma (pRCC) is a recognized subtype of renal cell carcinoma (RCC) with variable clinical and radiologic presentations. Exceptionally large tumors with metastatic involvement represent an unusual presentation. We report a case of a massive pRCC with metastatic disease, highlighting its aggressive clinical and radiologic features. A 50-year-old male presented with a right flank mass and abdominal pain persisting for several months. He had no history of smoking or known genetic syndromes. Laboratory investigations showed mild anemia and microscopic hematuria, while renal and liver function tests were within normal limits. Imaging studies, including computed tomography and magnetic resonance imaging, revealed a large centrally necrotic right renal mass measuring 24×19×31 cm, with associated lung and bone findings, concerning for metastases. A renal biopsy confirmed the diagnosis of papillary renal cell carcinoma.  This case highlights an atypical presentation of pRCC, with an exceptionally large tumor size, T2 hyperintensity, central necrosis, and radiologically suspected metastatic disease at the time of diagnosis. While pRCC is generally smaller, weakly enhancing, T2 hypointense, and less aggressive than clear cell RCC, this case demonstrates that exceptionally large renal masses may have atypical imaging appearances. Therefore, pRCC should remain within the differential diagnosis, and histopathological confirmation is required for definitive diagnosis. Management of metastatic pRCC should be individualized based on disease burden, resectability, patient factors, and available systemic treatment options. Further research is warranted to better understand the biological mechanisms underlying aggressive tumor behavior. This report aimed to highlight a rare case, emphasizing its clinical significance due to its unusual presentation, notable mass effect, complexities in differential diagnosis, and radiologically suspected metastatic involvement. Specifically, we describe a case involving a sizable, necrotic, and contrast-enhanced pRCC that deviates from the conventional clinical and radiological features commonly associated with this tumor subtype.
SN  - 2168-8184
ER  -